Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Amlodipine 5mg	267
Overall Study	STARTED	Amlodipine 10mg	276
Overall Study	STARTED	Telmisartan 40mg and Amlodipine 5mg	277
Overall Study	STARTED	Telmisartan 80mg and Amlodipine 5mg	277
Overall Study	COMPLETED	Amlodipine 5mg	255
Overall Study	COMPLETED	Amlodipine 10mg	252
Overall Study	COMPLETED	Telmisartan 40mg and Amlodipine 5mg	273
Overall Study	COMPLETED	Telmisartan 80mg and Amlodipine 5mg	266
Overall Study	NOT COMPLETED	Amlodipine 5mg	12
Overall Study	NOT COMPLETED	Amlodipine 10mg	24
Overall Study	NOT COMPLETED	Telmisartan 40mg and Amlodipine 5mg	4
Overall Study	NOT COMPLETED	Telmisartan 80mg and Amlodipine 5mg	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00558428/flow